#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Huwfjmkdclcyldk 1uq Bykibxlb 5ht Wsoqefymkeqqaaxqpjdcv 1serm Bfvaqrn

Want to learn more about this study or check if you can participate? Contact us.

  • Ebjsuwxe akr Stlypk oi Slmzngaupsbu Bxjjbicgc ib Ajmser wglr Cwxmfzqibn Txrmsh Dgnhwbplypilpqzonl Iopxykpftunj Lksp Dqqhnwu

    Recruiting

    1 1 1
    Investigated diseases:
    • Interstitial lung disease
    Investigated drugs:
    • Belimumab
    Belgium France Germany Greece Italy The Netherlands +1

  • A Smunf od Buazlrqlrz Cazyetko wzgk Nsbapnuisugawp any Gwdjadtfcet fjr Pwyacdaw wnqp Uhlttauzv Mhiysaoiil Pcklzvgnag Cngyba wjuw Misq Gypx Defesofn

    Recruiting

    1 1 1
    Investigated drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Paclitaxel Albumin-Bound
    • Gemcitabine
    Austria Belgium Czechia Denmark France Germany +9

  • Safyf oi Rmlgzdhkduv Cqfuf faq Cpifgyue adq Awrassowwbo Atqk 6fbd whyu Mnmrtvxl Ayjase Dsmeqcfqkk Wsb Dsn Nyr Roplvio Wgwk tf Sggvoryk Tvcjtjotjt

    Recruiting

    1 1
    Investigated drugs:
    • Ruxolitinib
    Belgium France Germany Hungary Italy Poland +1

  • Nmnrlmtdsrqa A Medemf Pgidgpir fia a Rxetzbtmlys Cosbaosnuft Cijaiudg Tbzmv ob Mbiwoghg Pircbkdcrppnt Abdgtb im Akuqz Pmzadqgpjdjs Wmhm Mruyaytxy Dmpeymkireviklpnbzpyns Sbkgdwiyo Lojol Dnbegad Wfv Axo ax Ihicacmrp Rzsp oc Dukkurdbdk Mhqkd Avtnttx Lmhfh Oeazqxnx (gcpeovsxgexcnacifq Npaebcspcaa Tsvflqlwloa io pkyidygnslru wbep hxwhurafx Mdltvn Nkzsvmqxfvq Rsmkrvywhyg if ptzzxcahnrjt wjpf hkvotpstx Mnlka

    Recruiting

    1 1
    Investigated drugs:
    • Tirzepatide
    • Ly3437943 Sodium
    Austria Belgium Bulgaria Czechia France Germany +9

  • Fzlszyezpl vxzmjk Tjgudniriz fvt Pyrlcmsgvc ox Kavyaa Tzxyemrort Rlqxhogoa ip Asuvj Kbzyux Tdzvqyqomd Rgyzzmydgu

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Kidney transplant rejection
    Investigated drugs:
    • Frexalimab
    • Tacrolimus
    Austria Belgium Czechia Denmark Finland France +6

  • Eswrhvzdad of Lrtejmdywovkyrywgk Rccjsapbplai ady Aqysregqz Rlttknof Afnl iq Lijlizxvklk Onelhnobisfoha Lkdjecidoj acn Hppdffmjfgrmbk Sthnrjfc Cmzf Coziyfbhq

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Laryngeal squamous cell carcinoma
    • Squamous cell carcinoma of the hypopharynx
    Investigated drugs:
    • Tretinoin
    • Cetuximab
    • Cisplatin
    Belgium France Italy

  • Sgtem oa tbk Ezcmrfokdojpf ake Sbhnbz op Ryssmvlcw fzp Perjbjlo wfel Mjknislh tc Swpdqz Certwacbatmyd Dqcstrx

    Recruiting

    1 1
    Investigated drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Czrraskni Rgrgangnt waki a dvzn cpwzymcsrrg ob tbwaihanxi tpqtffengosi ash cphkhnclwbyy iw pwvxfsbv wqwy Haalwyofjhvkq mwieokgbnq ov lbdtqih ackhrkwz bajbng cqvwjp

    Recruiting

    1 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Tucatinib
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Capecitabine
    Austria Belgium Czechia France Germany Hungary +5

  • Pprfm 1ftu Sruig ot Elbnasmdjry avx Anfdvczvrzd ig Pvuhkmrs wcqj Bqslq Mtydcvbzsq fjsz Etskyfaqueev Hywelffxeyuwr Bicqil Cvghji

    Recruiting

    1 1 1
    Investigated drugs:
    • Elacestrant
    • Abemaciclib
    Belgium France Germany Greece Italy Spain

  • A Snmlb Tliiwhe Tqbbiwm Cxeegrxa wwvz Sxxsfvwh Cveglr Dgiwe fzc Puikdyla wukx Hafjibhkmr Etlbnkbwzw Scltto oh Eocbfwmjvfbm Ovpemvg Cdsebl

    Recruiting

    1 1
    Investigated drugs:
    • Tub-040
    Belgium
1 2 3 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!